Français
ItalianoBond Organon & Co 5.125% ( US68622TAB70 ) in USD
| Issuer | Organon & Co | ||||||||
| Market price |  98.75 % ▲ |
||||||||
| Country |  United States
|
||||||||
| ISIN code |
 US68622TAB70 ( in USD )
|
||||||||
| Interest rate | 5.125% per year ( payment 2 times a year) | ||||||||
| Maturity | 04/30/2031 | ||||||||
| Minimal amount | 200 000 USD | ||||||||
| Total amount | 2 000 000 000 USD | ||||||||
| Cusip | 68622TAB7 | ||||||||
| Standard & Poor's ( S&P ) rating | BB- ( Non-investment grade speculative ) | ||||||||
| Moody's rating | B2 ( Highly speculative ) | ||||||||
| Next Coupon | 10/30/2026 ( In 5 days ) | ||||||||
| Detailed description |
Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands. The Bond issued by Organon & Co ( United States ) , in USD, with the ISIN code US68622TAB70, pays a coupon of 5.125% per year. The coupons are paid 2 times per year and the Bond maturity is 04/30/2031 The Bond issued by Organon & Co ( United States ) , in USD, with the ISIN code US68622TAB70, was rated B2 ( Highly speculative ) by Moody's credit rating agency. The Bond issued by Organon & Co ( United States ) , in USD, with the ISIN code US68622TAB70, was rated BB- ( Non-investment grade speculative ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||
| |||||||||